1-4 of 4
F. Swan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ASHAP: A Regimen for Cytoreduction of Refractory or Recurrent Hodgkin’s Disease

J. Rodriguez, M.A. Rodriguez, L. Fayad, P. McLaughlin, F. Swan, A. Sarris, J. Romaguera, B. Andersson, F. Cabanillas, F.B. Hagemeister
Journal: Blood
Blood (1999) 93 (11): 3632–3636.
https://doi.org/10.1182/blood.V93.11.3632
Published: 1999
Journal Articles

Stages I and II diffuse large cell lymphomas: prognostic factors and long-term results with CHOP-bleo and radiotherapy

WS Velasquez, LM Fuller, S Jagannath, SL Tucker, LB North, FB Hagemeister, P McLaughlin, F Swan, JR Redman, MA Rodriguez
Journal: Blood
Blood (1991) 77 (5): 942–947.
https://doi.org/10.1182/blood.V77.5.942.942
Published: 1991
Journal Articles

Risk classification as the basis for clinical staging of diffuse large- cell lymphoma derived from 10-year survival data

WS Velasquez, S Jagannath, SL Tucker, LM Fuller, LB North, JR Redman, F Swan, FB Hagemeister, P McLaughlin, F Cabanillas
Journal: Blood
Blood (1989) 74 (2): 551–557.
https://doi.org/10.1182/blood.V74.2.551.551
Published: 1989
Journal Articles

Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)

WS Velasquez, F Cabanillas, P Salvador, P McLaughlin, M Fridrik, S Tucker, S Jagannath, FB Hagemeister, JR Redman, F Swan
Journal: Blood
Blood (1988) 71 (1): 117–122.
https://doi.org/10.1182/blood.V71.1.117.117
Published: 1988